Global Enteric Disease Testing Devices Market Size By Type (Immunoassay Testing, Conventional Testing), By Application (Bacterial Enteric Diseases, Viral Enteric Diseases), By Region, And Segment Fore...

lobal Enteric Disease Testing Devices Market Report Description

The Global Enteric Disease Testing Devices Market was valued at USD 3.1 billion in 2023 and is projected to surpass USD 5.6 billion by 2031, growing at a CAGR of 7.8% during the forecast period of 2023–2031. Rising global incidences of foodborne illnesses, the expansion of point-of-care diagnostics, and increasing public health initiatives for gastrointestinal disease management are major factors driving market growth. With enteric infections posing significant public health concerns, especially in developing nations, the demand for rapid and accurate testing devices continues to escalate.

Drivers:

1. Increasing Prevalence of Enteric Infections:

The growing burden of enteric diseases caused by pathogens like E. coli, Salmonella, and Rotavirus is compelling healthcare systems to adopt advanced diagnostic solutions for timely detection and management.

2. Advancements in Diagnostic Technologies:

Innovations in molecular diagnostics and immunoassays have significantly improved the sensitivity and specificity of enteric disease detection, leading to increased adoption of sophisticated testing devices in both clinical and point-of-care settings.

3. Government and NGO Support for Disease Control:

Supportive healthcare policies and disease surveillance programs led by government and global health organizations are creating a favorable environment for market expansion.

Restraints:

1. High Cost of Advanced Testing Devices:

The adoption of technologically advanced diagnostic devices is often hindered by high costs, particularly in low-income and resource-constrained regions.

2. Limited Laboratory Infrastructure in Rural Areas:

Inadequate healthcare infrastructure and diagnostic facilities in remote and rural areas restrict timely disease detection and limit market penetration.

Opportunity:

1. Growth of Home and Point-of-Care Testing:

The emergence of rapid diagnostic tests that are easy to use and do not require laboratory settings is transforming the market landscape, making enteric disease testing more accessible and scalable.

2. Expanding Healthcare Investments in Emerging Markets:

Increased government investments in healthcare infrastructure and growing awareness about infectious diseases in Asia-Pacific and Africa present lucrative growth opportunities for market players.

Market by System Type Insights:

By system type, the Molecular Diagnostic Systems segment accounted for the largest market share in 2023. These systems offer superior accuracy and are increasingly preferred for detecting enteric pathogens due to their ability to rapidly identify multiple targets in a single test. Meanwhile, Immunoassay-Based Systems are gaining traction due to their cost-effectiveness and ease of use in decentralized settings.

Market by End-use Insights:

In 2023, Hospitals and Diagnostic Laboratories held the dominant market share, owing to their access to high-throughput diagnostic technologies and skilled personnel. However, the Home Care and Point-of-Care Settings segment is projected to witness the fastest growth, driven by the rising demand for convenience and real-time results.

Market by Regional Insights:

North America led the global market in 2023, supported by well-established healthcare systems, high awareness levels, and significant R&D investments. Asia-Pacific is expected to register the highest CAGR during the forecast period, fueled by improving diagnostic infrastructure, growing healthcare expenditure, and a high burden of enteric infections in densely populated countries like India and China.

Competitive Scenario:

Key players in the Global Enteric Disease Testing Devices Market include bioMérieux SA, Thermo Fisher Scientific Inc., Abbott Laboratories, QuidelOrtho Corporation, Meridian Bioscience, Inc., Becton, Dickinson and Company, Bio-Rad Laboratories, Inc., and Cepheid. These companies are actively focusing on expanding their product portfolios, adopting strategic collaborations, and enhancing R&D investments to strengthen their market position.

Scope of Work – Global Enteric Disease Testing Devices Market

Report Metric Details

Market Size (2023) USD 3.1 billion

Projected Market Size (2031) USD 5.6 billion

CAGR (2023–2031) 7.8%

Market Segments By System Type (Molecular Diagnostics, Immunoassays), By End-use (Hospitals, Diagnostic Labs, Home Care)

Growth Drivers Increasing prevalence of enteric infections, Technological advancements, Public health initiatives

Opportunities Point-of-care testing adoption, Emerging market expansion

Key Market Developments:

2023: bioMérieux SA launched a next-gen multiplex PCR panel for comprehensive enteric pathogen detection, improving diagnostic turnaround times.

2024: Abbott Laboratories received FDA clearance for its rapid enteric infection test for decentralized clinical settings.

2025: Thermo Fisher Scientific expanded its production facilities in Asia to support incre